Trade OXFORD BIOMEDICA PLC ORD 50P - OXB CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.078 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023252% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001334% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | GBP | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United Kingdom of Great Britain and Northern Ireland | ||||||||
| Commission on trade | 0% |
| Prev. Close | 3.666 |
| Open | 3.651 |
| 1-Year Change | 117.84% |
| Day's Range | 3.376 - 3.701 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 3.426 | -0.225 | -6.16% | 3.651 | 3.721 | 3.361 |
| Feb 20, 2025 | 3.666 | -0.075 | -2.00% | 3.741 | 3.826 | 3.656 |
| Feb 19, 2025 | 3.746 | -0.035 | -0.93% | 3.781 | 3.871 | 3.716 |
| Feb 18, 2025 | 3.851 | 0.000 | 0.00% | 3.851 | 3.896 | 3.736 |
| Feb 17, 2025 | 3.881 | 0.100 | 2.64% | 3.781 | 3.896 | 3.646 |
| Feb 14, 2025 | 3.896 | 0.065 | 1.70% | 3.831 | 3.906 | 3.756 |
| Feb 13, 2025 | 3.816 | -0.030 | -0.78% | 3.846 | 3.926 | 3.801 |
| Feb 12, 2025 | 3.826 | -0.050 | -1.29% | 3.876 | 3.951 | 3.821 |
| Feb 11, 2025 | 3.871 | 0.010 | 0.26% | 3.861 | 3.961 | 3.826 |
| Feb 10, 2025 | 3.871 | -0.049 | -1.25% | 3.920 | 3.995 | 3.866 |
| Feb 7, 2025 | 3.891 | -0.049 | -1.24% | 3.940 | 4.050 | 3.891 |
| Feb 6, 2025 | 4.035 | -0.055 | -1.34% | 4.090 | 4.095 | 3.955 |
| Feb 5, 2025 | 4.065 | 0.030 | 0.74% | 4.035 | 4.090 | 3.970 |
| Feb 4, 2025 | 3.995 | -0.020 | -0.50% | 4.015 | 4.185 | 3.940 |
| Feb 3, 2025 | 3.975 | -0.045 | -1.12% | 4.020 | 4.110 | 3.975 |
| Jan 31, 2025 | 4.145 | 0.010 | 0.24% | 4.135 | 4.245 | 4.055 |
| Jan 30, 2025 | 4.125 | -0.055 | -1.32% | 4.180 | 4.185 | 4.030 |
| Jan 29, 2025 | 4.120 | -0.180 | -4.19% | 4.300 | 4.460 | 4.120 |
| Jan 28, 2025 | 4.435 | 0.290 | 7.00% | 4.145 | 4.520 | 4.070 |
| Jan 27, 2025 | 4.135 | 0.040 | 0.98% | 4.095 | 4.150 | 4.030 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Oxford BioMedica plc Company profile
About Oxford BioMedica plc
Oxford BioMedica Plc is a United Kingdom-based gene and cell therapy company. The Company and its subsidiaries have developed lentiviral vector delivery system, LentiVector platform, which the Company leverages to develop in vivo and ex vivo products both in-house and with partners. Its LentiVector delivery platform has created a portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology, central nervous system (CNS) disorders and liver diseases. The Company's product pipeline includes OXB-302, OXB-203, OXB-204 and OXB-103 and OXB-401. The Company has also developed partnership with various pharmaceutical companies to develop potential gene and cell therapy products. Its partnered products include AXO-LENTI-PD, SAR 422459 and SAR421869.
Financial summary
BRIEF: For the six months ended 30 June 2021, Oxford BioMedica plc revenues increased from £34M to £81.3M. Net income totaled £18.1M vs. loss of £6.7M. Revenues reflect Europe segment increase from £19M to £70.3M. Net Income reflects Platform segment income totaling £24.4M vs. loss of £3.1M. Basic Earnings per Share excluding Extraordinary Items increased from -£0.09 to £0.22.
Equity composition
10/2003, Rights Issue, 27 new shs for every 50 shs held @ GBP 0.17 (Fct:1.54). 03/2001, Rights Issue, 1 new share for every 9 shs held @ GBP 0.55 (Fct:1.111111). 03/1998, Rights Issue, 1 new share for every 4 shs held @ GBP 0.10 (Fct:1.076). 05/2014, Priority Issue, 1 new shares for every 5 shares held @ GBp 2 (Factor:1).
| Industry: | Bio Therapeutic Drugs |
Windrush Court
Transport Way
OXFORD
OXFORDSHIRE OX4 6LT
GB
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com